Viewing Study NCT02114203


Ignite Creation Date: 2025-12-24 @ 7:17 PM
Ignite Modification Date: 2026-02-08 @ 3:44 AM
Study NCT ID: NCT02114203
Status: COMPLETED
Last Update Posted: 2017-12-14
First Post: 2014-04-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Study Of PF-04447943, Co-Administered With And Without Hydroxyurea, In Subjects With Stable Sickle Cell Disease
Sponsor: Pfizer
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: B0401016
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators